文献速递妇科生殖医学

小细胞外囊泡-miRNA在子宫内膜异位症中的作用

The role of small extracellular vesicle-miRNAs in endometriosis.
PubMed 文献 · Hum Reprod · 2023-01-01

本文为小型综述,聚焦小细胞外囊泡(sEV)携带的miRNA在子宫内膜异位症中的作用。sEV-miRNA参与巨噬细胞免疫调节、子宫内膜细胞增殖迁移侵袭及血管生成等过程;一项研究报道两种sEV-miRNA可区分子宫内膜异位症与非子宫内膜异位症,仅三项小鼠研究探索其治疗潜力;研究受限于未遵循国际细胞外囊泡学会2018年指南及世界子宫内膜异位症研究基金会表型与生物样本库统一方案。

要点

  • sEV-miRNA参与免疫调节、细胞增殖迁移侵袭和血管生成等子宫内膜异位症特征过程。
  • 一项研究报道hsa-miR-22-3p和hsa-miR-320a-3p可区分子宫内膜异位症与非子宫内膜异位症。
  • 仅三项小鼠研究探索sEV-miRNA治疗潜力,研究受限于未遵循分离鉴定指南与统一方案。

核心结论

  • sEV-miRNA可能成为子宫内膜异位症有吸引力的未来诊断和治疗靶点,但早期结果虽令人鼓舞,仍需进一步研究月经周期及病灶位置和范围等因素对sEV中miRNA表达的影响;该领域研究受限于未遵循国际细胞外囊泡学会2018年指南及世界子宫内膜异位症研究基金会子宫内膜异位症表型与生物样本库统一方案。

研究设计与样本

  • 本文为小型综述,聚焦sEV-miRNA在子宫内膜异位症中的作用。
  • 子宫内膜异位症定义为子宫外存在子宫内膜样组织,可在10%育龄女性中引起疼痛和不孕。
  • sEV为小于200 nm的细胞来源囊泡,携带可影响靶细胞基因表达和行为的分子;miRNA为长度多为19-25个核苷酸的非编码RNA,调控转录后基因表达。

主要发现

  • sEV-miRNA参与巨噬细胞免疫调节、子宫内膜细胞增殖迁移侵袭及血管生成,均为子宫内膜异位症特征。
  • 一项研究报道两种sEV-miRNA(hsa-miR-22-3p和hsa-miR-320a-3p)区分子宫内膜异位症与非子宫内膜异位症的敏感性和特异性。
  • 仅三项研究在小鼠体内探索sEV-miRNA治疗潜力:两项研究sEV-hsa-miR-214-3p减少纤维化,一项研究sEV-hsa-miR-30c-5p抑制子宫内膜异位病灶的侵袭和迁移潜能。
  • sEV-miRNA conceivably较游离miRNA是更好的生物标志物,因sEV包裹的miRNA受保护免于降解,并通过sEV表面蛋白提供直接细胞间通讯。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 研究需进一步探讨月经周期以及子宫内膜异位病灶位置和范围等因素对sEV中miRNA表达的潜在影响。
  • 该领域研究受限于未遵循国际细胞外囊泡学会2018年指南分离和鉴定sEV。
  • 该领域研究受限于未遵循世界子宫内膜异位症研究基金会子宫内膜异位症表型与生物样本库统一方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Endometriosis is defined by the presence of extrauterine endometrial-like tissue, which can cause pain and infertility in 10% of reproductive-age women. To date, the pathogenesis is poorly understood resulting in significant diagnostic delays and poor therapeutic outcomes in many women. Small extracellular vesicles (sEVs) (<200 nm) are cell-derived vesicles containing molecules that can influence gene expression and behaviour in target cells. One such cargo are microRNAs (miRNAs), which are short, non-coding RNAs mostly 19-25 nucleotides in length that regulate post-transcriptional gene expression. This mini-review focuses on the role of sEV-miRNAs, which are conceivably better biomarkers for endometriosis than free miRNAs, which reflect the true pathophysiological state in the body, as sEV-encapsulated miRNAs are protected from degradation compared to free miRNA and provide direct cell-to-cell communication via sEV surface proteins. sEV-miRNAs have been implicated in the immunomodulation of macrophages, the proliferation, migration and invasion of endometrial cells, and angiogenesis, all hallmarks of endometriosis. The diagnostic potential of sEV-miRNA was investigated in one study that reported the sensitivity and specificity of two sEV-miRNAs (hsa-miR-22-3p and hsa-miR-320a-3p) in distinguishing endometriosis from non-endometriosis cases. Only three studies have explored the therapeutic potential of sEV-miRNAs in vivo in mice-two looked into the role of sEV-hsa-miR-214-3p in decreasing fibrosis, and one investigated sEV-hsa-miR-30c-5p in suppressing the invasive and migratory potential of endometriotic lesions. While early results are encouraging, studies need to further address the potential influence of factors such as the menstrual cycle as well as the location and extent of endometriotic lesions on miRNA expression in sEVs. Given these findings, and extrapolating from other conditions such as cancer, diabetes, and pre-eclampsia, sEV-miRNAs could present an attractive and urgently needed future diagnostic and therapeutic target for millions of women suffering from endometriosis. However, research in this area is hampered by lack of adherence to the International Society for Extracellular Vesicles 2018 guideline in separating and characterising sEVs, as well as the World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project protocols.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Nazri HM, Greaves E, Quenby S, et al. The role of small extracellular vesicle-miRNAs in endometriosis. Hum Reprod. 2023. PMID: 37877421. doi:10.1093/humrep/dead216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。